Synthetic organizers provide a way to control formation of kidney organoids as more reliable models for studying disease and ...
Over the past two decades, high‑throughput sequencing has dramatically expanded our understanding of the gut microbiome's composition.
Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...
The gut microbiome is not a mere spectator but an active player in colorectal cancer (CRC), driving tumor initiation and ...
One of the most detailed maps to date of meningioma, the most common brain tumor in adults, reveals how the tumor’s ...
SCI often causes long-term motor and sensory deficits because the damaged tissue does not simply heal like many peripheral tissues.
This article explores how new technologies in plasma proteomics enable the simultaneous analysis of thousands of proteins, ...
While agents like AbbVie's Humira have transformed the treatment landscape, not all patients benefit equally from the drug.
Morning Overview on MSN
Two cancer drugs already on pharmacy shelves reversed Alzheimer’s damage in mice
Researchers have identified two FDA-approved cancer drugs, letrozole and irinotecan, that reversed Alzheimer’s-related brain ...
Climate Compass on MSN
The quiet science revolution nobody is talking about - and why it changes everything
There is a particular kind of progress that doesn't make the front page. It doesn't arrive with a press release or a prime-time announcement. It accumulates - in journals, in labs, in the slow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results